$57.00
-0.25-0.44%
At close: -
$56.60
-0.40-0.70%
After Hours: Feb 19, 6:40 AM EDT
Belite Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Belite Bio using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.28 | $-0.29 | 3.45 % |
Q2 | 2024-08-09 | $-0.26 | $-0.25 | -4.00 % |
Q1 | 2024-05-13 | $-0.33 | $-0.28 | -17.9 % |
Q4 | 2024-03-11 | $-0.25 | $-0.30 | 16.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Belite Bio (BLTE) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.28, which beat the estimate of $-0.29.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.